{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T23:48:05Z","timestamp":1775260085269,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer US","isbn-type":[{"value":"9781071648476","type":"print"},{"value":"9781071648483","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4848-3_14","type":"book-chapter","created":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T10:14:11Z","timestamp":1762164851000},"page":"225-236","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Conjugation of Saccharidic Synthetic Antigens with Carrier Proteins by the Squaric Acid Method: Application as Biomarkers for Treatment Evaluation in Chagas Disease"],"prefix":"10.1007","author":[{"given":"M. Eugenia","family":"Giorgi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda Toro","family":"Melgarejo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esteban","family":"Bodmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Marino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"issue":"Suppl 1","key":"14_CR1","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1590\/s0074-02762009000900017","volume":"104","author":"YM Gomes","year":"2009","unstructured":"Gomes YM, Lorena VM, Luquetti AO (2009) Diagnosis of Chagas disease: what has been achieved? What remains to be done with regard to diagnosis and follow up studies? Mem Inst Oswaldo Cruz 104(Suppl 1):115\u2013121. https:\/\/doi.org\/10.1590\/s0074-02762009000900017","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"7904","key":"14_CR2","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0140-6736(75)91492-0","volume":"305","author":"A Voller","year":"1975","unstructured":"Voller A, Draper C, Bidwell D, Bartlett A (1975) Microplate enzyme-linked immunosorbent assay for Chagas\u2019 disease. Lancet 305(7904):426\u2013428. https:\/\/doi.org\/10.1016\/S0140-6736(75)91492-0","journal-title":"Lancet"},{"key":"14_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apar.2016.10.001","volume":"97","author":"V Balouz","year":"2017","unstructured":"Balouz V, Ag\u00fcero F, Buscaglia CA (2017) Chagas disease diagnostic applications: present knowledge and future steps. Adv Parasitol 97:1\u201345. https:\/\/doi.org\/10.1016\/bs.apar.2016.10.001","journal-title":"Adv Parasitol"},{"issue":"11","key":"14_CR4","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1128\/cvi.05289-11","volume":"18","author":"CR De Marchi","year":"2011","unstructured":"De Marchi CR, Di Noia JM, Frasch AC, Amato Neto V, Almeida IC, Buscaglia CA (2011) Evaluation of a recombinant Trypanosoma cruzi mucin-like antigen for serodiagnosis of Chagas\u2019 disease. Clin Vaccine Immunol 18(11):1850\u20131855. https:\/\/doi.org\/10.1128\/cvi.05289-11","journal-title":"Clin Vaccine Immunol"},{"issue":"Pt 3","key":"14_CR5","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1042\/bj3040793","volume":"304","author":"IC Almeida","year":"1994","unstructured":"Almeida IC, Ferguson MA, Schenkman S, Travassos LR (1994) Lytic anti-alpha-galactosyl antibodies from patients with chronic Chagas\u2019 disease recognize novel O-linked oligosaccharides on mucin-like glycosyl-phosphatidylinositol-anchored glycoproteins of Trypanosoma cruzi. Biochem J 304(Pt 3):793\u2013802. https:\/\/doi.org\/10.1042\/bj3040793","journal-title":"Biochem J"},{"issue":"16","key":"14_CR6","doi-asserted-by":"publisher","first-page":"15860","DOI":"10.1074\/jbc.M314051200","volume":"279","author":"CA Buscaglia","year":"2004","unstructured":"Buscaglia CA, Campo VA, Di Noia JM, Torrecilhas ACT, De Marchi CR, Ferguson MAJ, Frasch AC, Almeida IC (2004) The surface coat of the mammal-dwelling infective Trypomastigote stage of Trypanosoma cruzi is formed by highly diverse immunogenic mucins. J Biol Chem 279(16):15860\u201315869. https:\/\/doi.org\/10.1074\/jbc.M314051200","journal-title":"J Biol Chem"},{"issue":"1","key":"14_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/imm.13582","volume":"168","author":"U Galili","year":"2023","unstructured":"Galili U (2023) Paleo-immunology of human anti-carbohydrate antibodies preventing primate extinctions. Immunology 168(1):18\u201329. https:\/\/doi.org\/10.1111\/imm.13582","journal-title":"Immunology"},{"issue":"12","key":"14_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-052897","volume":"11","author":"C Alonso-Vega","year":"2021","unstructured":"Alonso-Vega C, Urbina JA, Sanz S, Pinazo M-J, Pinto JJ, Gonzalez VR, Rojas G, Ortiz L, Garcia W, Lozano D, Soy D, Maldonado RA, Nagarkatti R, Debrabant A, Schijman A, Thomas MC, L\u00f3pez MC, Michael K, Ribeiro I, Gascon J, Torrico F, Almeida IC (2021) New chemotherapy regimens and biomarkers for Chagas disease: the rationale and design of the TESEO study, an open-label, randomised, prospective, phase-2 clinical trial in the Plurinational State of Bolivia. BMJ Open 11(12):e052897. https:\/\/doi.org\/10.1136\/bmjopen-2021-052897","journal-title":"BMJ Open"},{"issue":"34","key":"14_CR9","doi-asserted-by":"publisher","first-page":"5579","DOI":"10.1039\/C3OB40887F","volume":"11","author":"RA Ashmus","year":"2013","unstructured":"Ashmus RA, Schocker NS, Cordero-Mendoza Y, Marques AF, Monroy EY, Pardo A, Izquierdo L, G\u00e1llego M, Gascon J, Almeida IC, Michael K (2013) Potential use of synthetic \u03b1-galactosyl-containing glycotopes of the parasite Trypanosoma cruzi as diagnostic antigens for Chagas disease. Org Biomol Chem 11(34):5579\u20135583. https:\/\/doi.org\/10.1039\/C3OB40887F","journal-title":"Org Biomol Chem"},{"issue":"12","key":"14_CR10","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1021\/acsinfecdis.6b00114","volume":"2","author":"CRN Brito","year":"2016","unstructured":"Brito CRN, McKay CS, Azevedo MA, Santos LCB, Venuto AP, Nunes DF, D\u2019\u00c1vila DA, Rodrigues da Cunha GM, Almeida IC, Gazzinelli RT, Galv\u00e3o LMC, Chiari E, Sanhueza CA, Finn MG, Marques AF (2016) Virus-like particle display of the \u03b1-gal epitope for the diagnostic assessment of Chagas disease. ACS Infect Dis 2(12):917\u2013922. https:\/\/doi.org\/10.1021\/acsinfecdis.6b00114","journal-title":"ACS Infect Dis"},{"issue":"1","key":"14_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41541-019-0107-7","volume":"4","author":"S Portillo","year":"2019","unstructured":"Portillo S, Zepeda BG, Iniguez E, Olivas JJ, Karimi NH, Moreira OC, Marques AF, Michael K, Maldonado RA, Almeida IC (2019) A prophylactic \u03b1-gal-based glycovaccine effectively protects against murine acute Chagas disease. NPJ Vaccines 4(1):13. https:\/\/doi.org\/10.1038\/s41541-019-0107-7","journal-title":"NPJ Vaccines"},{"key":"14_CR12","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1007\/978-1-4939-9148-8_22","volume-title":"Methods in molecular biology","author":"U Ortega-Rodriguez","year":"2019","unstructured":"Ortega-Rodriguez U, Portillo S, Ashmus RA, Duran JA, Schocker NS, Eva I, Montoya AL, Zepeda BG, Olivas JJ, Karimi NH, Alonso-Padilla J, Izquierdo L, Pinazo M-J, de Noya BA, Noya O, Maldonado RA, Torrico F, Gascon J, Michael K, Almeida IC (2019) Purification of glycosylphosphatidylinositol-anchored mucins from Trypanosoma cruzi trypomastigotes and synthesis of \u03b1-gal-containing neoglycoproteins: application as biomarkers for reliable diagnosis and early assessment of chemotherapeutic outcomes of Chagas disease. In: G\u00f3mez KA, Buscaglia CA (eds) Methods in molecular biology. Springer, New York, pp 287\u2013308. https:\/\/doi.org\/10.1007\/978-1-4939-9148-8_22. PMID: 30868536"},{"key":"14_CR13","doi-asserted-by":"publisher","first-page":"5714","DOI":"10.3390\/molecules27175714","volume":"27","author":"AL Montoya","year":"2022","unstructured":"Montoya AL, Carvajal EG, Ortega-Rodriguez U, Estevao IL, Ashmus RA, Jankuru SR, Portillo S, Ellis CC, Knight CD, Alonso-Padilla J, Izquierdo L, Pinazo M-J, Gascon J, Suarez V, Watts DM, Malo IR, Ramsey JM, De Noya AB, Noya O, Almeida IC, Michael K (2022) A branched and double alpha-gal-bearing synthetic neoglycoprotein as a biomarker for Chagas disease. Molecules 27:5714. https:\/\/doi.org\/10.3390\/molecules27175714. PMID: 36080480","journal-title":"Molecules"},{"key":"14_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.carres.2019.04.007","volume":"478","author":"R Lopez","year":"2019","unstructured":"Lopez R, Giorgi ME, Melgarejo LT, Ducrey I, Balouz V, Gonz\u00e1lez-Salas D, C\u00e1mara MM, Buscaglia CA, de Lederkremer RM, Marino C (2019) Synthesis and characterization of \u03b1-D-Galp-(1\u00a0\u2192\u00a03)-\u03b2-D-Galp epitope-containing neoglycoconjugates for Chagas disease serodiagnosis. Carbohydr Res 478:58\u201367. https:\/\/doi.org\/10.1016\/j.carres.2019.04.007","journal-title":"Carbohydr Res"},{"issue":"1","key":"14_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0011910","volume":"18","author":"M Abal","year":"2024","unstructured":"Abal M, Balouz V, Lopez R, Giorgi ME, Marino C, Cruz CV, Altcheh J, Buscaglia CA (2024) An \u03b1-Gal antigenic surrogate as a biomarker of treatment evaluation in Trypanosoma cruzi-infected children. A retrospective cohort study. PLoS Negl Trop Dis 18(1):e0011910. https:\/\/doi.org\/10.1371\/journal.pntd.0011910","journal-title":"PLoS Negl Trop Dis"},{"key":"14_CR16","doi-asserted-by":"publisher","DOI":"10.1039\/9781782626657-00083","volume-title":"Carbohydrate chemistry","author":"P Kov\u00e1\u010d","year":"2016","unstructured":"Kov\u00e1\u010d P, Xu P (2016) Controlled and highly efficient preparation of carbohydrate-based vaccines: squaric acid chemistry is the way to go. In: Pilar Rauter A, Lindhorst T, Queneau Y (eds) Carbohydrate chemistry, vol 42. The Royal Society of Chemistry, London"},{"issue":"3","key":"14_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1021\/bc00009a003","volume":"2","author":"LF Tietze","year":"1991","unstructured":"Tietze LF, Schroeter C, Gabius S, Brinck U, Goerlach-Graw A, Gabius HJ (1991) Conjugation of p-aminophenyl glycosides with squaric acid diester to a carrier protein and the use of the neoglycoprotein in the histochemical detection of lectins. Bioconjug Chem 2(3):148\u2013153. https:\/\/doi.org\/10.1021\/bc00009a003","journal-title":"Bioconjug Chem"},{"key":"14_CR18","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0076-6879(03)01010-3","volume":"362","author":"R Saksena","year":"2003","unstructured":"Saksena R, Chernyak A, Karavanov A, Kov\u00e1c P (2003) Conjugating low molecular mass carbohydrates to proteins 1. Monitoring the progress of conjugation. Methods Enzymol 362:125\u2013139. https:\/\/doi.org\/10.1016\/s0076-6879(03)01010-3","journal-title":"Methods Enzymol"},{"issue":"2","key":"14_CR19","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.carres.2007.10.015","volume":"343","author":"S-J Hou","year":"2008","unstructured":"Hou S-J, Saksena R, Kov\u00e1\u010d P (2008) Preparation of glycoconjugates by dialkyl squarate chemistry revisited. Carbohydr Res 343(2):196\u2013210. https:\/\/doi.org\/10.1016\/j.carres.2007.10.015","journal-title":"Carbohydr Res"},{"key":"14_CR20","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/978-1-4939-9154-9_8","volume":"1954","author":"P Xu","year":"2019","unstructured":"Xu P, Kov\u00e1\u010d P (2019) Direct conjugation of bacterial polysaccharides to proteins by squaric acid chemistry. Methods Mol Biol 1954:89\u201398. https:\/\/doi.org\/10.1007\/978-1-4939-9154-9_8","journal-title":"Methods Mol Biol"},{"issue":"8","key":"14_CR21","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1002\/cbic.201600699","volume":"18","author":"P Xu","year":"2017","unstructured":"Xu P, Kelly M, Vann WF, Qadri F, Ryan ET, Kov\u00e1\u010d P (2017) Conjugate vaccines from bacterial antigens by squaric acid chemistry: a closer look. Chembiochem 18(8):799\u2013815. https:\/\/doi.org\/10.1002\/cbic.201600699","journal-title":"Chembiochem"},{"issue":"24","key":"14_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.126263","volume":"42","author":"M Kelly","year":"2024","unstructured":"Kelly M, Janardhanan J, Wagh C, Verma S, Charles RC, Leung DT, Kamruzzaman M, Pansuriya RK, Chowdhury F, Vann WF, Kaminski RW, Khan AI, Bhuiyan TR, Qadri F, Kov\u00e1\u010d P, Xu P, Ryan ET (2024) Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge. Vaccine 42(24):126263. https:\/\/doi.org\/10.1016\/j.vaccine.2024.126263","journal-title":"Vaccine"},{"issue":"3","key":"14_CR23","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1021\/acsinfecdis.1c00585","volume":"8","author":"Z Rashidijahanabad","year":"2022","unstructured":"Rashidijahanabad Z, Kelly M, Kamruzzaman M, Qadri F, Bhuiyan TR, McFall-Boegeman H, Wu D, Piszczek G, Xu P, Ryan ET, Huang X (2022) Virus-like particle display of vibrio choleraeO-specific polysaccharide as a potential vaccine against cholera. ACS Infect Dis 8(3):574\u2013583. https:\/\/doi.org\/10.1021\/acsinfecdis.1c00585","journal-title":"ACS Infect Dis"},{"issue":"21","key":"14_CR24","doi-asserted-by":"publisher","first-page":"8220","DOI":"10.1039\/C3CS60153F","volume":"42","author":"FR Wurm","year":"2013","unstructured":"Wurm FR, Klok H-A (2013) Be squared: expanding the horizon of squaric acid-mediated conjugations. Chem Soc Rev 42(21):8220\u20138236. https:\/\/doi.org\/10.1039\/C3CS60153F","journal-title":"Chem Soc Rev"},{"key":"14_CR25","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.carres.2017.08.007","volume":"450","author":"ME Giorgi","year":"2017","unstructured":"Giorgi ME, Lopez R, Agusti R, Marino C, de Lederkremer RM (2017) Synthesis of a model trisaccharide for studying the interplay between the anti \u03b1-Gal antibody and the trans-sialidase reactions in Trypanosoma cruzi. Carbohydr Res 450:30\u201337. https:\/\/doi.org\/10.1016\/j.carres.2017.08.007","journal-title":"Carbohydr Res"},{"issue":"16","key":"14_CR26","doi-asserted-by":"publisher","first-page":"3267","DOI":"10.1016\/S0040-4020(01)00196-X","volume":"57","author":"S Hanessian","year":"2001","unstructured":"Hanessian S, Saavedra OM, Mascitti V, Marterer W, Oehrlein R, Mak C-P (2001) Practical syntheses of B disaccharide and linear B type 2 trisaccharide-non-primate epitope markers recognized by human anti-\u03b1-Gal antibodies causing hyperacute rejection of xenotransplants. Tetrahedron 57(16):3267\u20133280. https:\/\/doi.org\/10.1016\/S0040-4020(01)00196-X","journal-title":"Tetrahedron"}],"container-title":["Methods in Molecular Biology","T. cruzi Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4848-3_14","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T22:30:04Z","timestamp":1775255404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4848-3_14"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,4]]},"ISBN":["9781071648476","9781071648483"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4848-3_14","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,4]]},"assertion":[{"value":"4 November 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}